BSAC standardized disc susceptibility testing method (version 7)
JMJ. M. AndrewsFTfor the BSAC Working Party on Susceptibility Testing
Indexed incrossrefpubmed
Abstract
The changes that have been made to the previous version of the recommendations (version 6) are as follows: medium and incubation condition for testing Acinetobacter spp. (Tables 1 and 6); use of cefoxitin as an indicator antibiotic for detecting methicillin/oxacillin/cefoxitin resistance in coagulase-negative staphylococci (Tables 1, 6 and 11); MIC breakpoint for co-trimoxazole based on the trimethoprim concentration in a 1:19 combination with sulfamethoxazole (Tables 7, 10, 11, 12, 15, 16 and 19); advice on the use of azithromycin for the treatment of infections with Salmonella typhi (footnote to Table 7); amendment to the recommendation for cefuroxime for the treatment of infections with Proteus mirabilis…
Citation impact
738
total citations
- FWCI
- 35.69
- Percentile
- 100%
- References
- 19
Citations per year
Authors
2- JMJ. M. AndrewsCorresponding
Birmingham City Hospital
- FTfor the BSAC Working Party on Susceptibility Testing
Topics & keywords
Topics
Keywords
- Microbiology
- Cefoxitin
- Population
- Cefuroxime
- Breakpoint
- Ciprofloxacin
- Biology
- Medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.